MXCT (STOCKS)
MaxCyte, Inc. Common Stock
$0.813100
+0.021700 (+2.74%)
Prev close: $0.791400
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Maher Masoud
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $86.89M
- Employees
- 114
- P/E (TTM)
- -1.89
- P/B (TTM)
- 0.49
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.06 | $-0.08 | +0.0216 | +26.47% |
|
Sep 2025 (Q3)
|
$-0.09 | $-0.11 | +0.0222 | +19.79% |
|
Jun 2025 (Q2)
|
$-0.12 | $-0.11 | -0.0146 | -13.85% |
|
Mar 2025 (Q1)
|
$-0.10 | $-0.11 | +0.0071 | +6.63% |
Financial Statements
| Revenues | $33.03M |
| Benefits Costs and Expenses | $77.66M |
| Cost Of Revenue | $6.22M |
| Costs And Expenses | $77.66M |
| Gross Profit | $26.80M |
| Operating Expenses | $78.70M |
| Depreciation and Amortization | $4.23M |
| Research and Development | $20.82M |
| Other Operating Expenses | $53.65M |
| Operating Income/Loss | -$51.90M |
| Income/Loss From Continuing Operations After Tax | -$44.63M |
| Income/Loss From Continuing Operations Before Tax | -$44.63M |
| Net Income/Loss | -$44.63M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$44.63M |
| Net Income/Loss Available To Common Stockholders, Basic | -$44.63M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.42 |
| Diluted Earnings Per Share | -$0.42 |
| Basic Average Shares | 106,427,854 |
| Diluted Average Shares | 106,427,854 |
| Assets | $202.51M |
| Current Assets | $118.37M |
| Inventory | $7.55M |
| Other Current Assets | $110.82M |
| Noncurrent Assets | $84.14M |
| Fixed Assets | $17.53M |
| Intangible Assets | $650.00K |
| Other Non-current Assets | $65.96M |
| Liabilities | $31.02M |
| Current Liabilities | $14.27M |
| Accounts Payable | $1.40M |
| Other Current Liabilities | $12.87M |
| Noncurrent Liabilities | $16.75M |
| Equity | $171.49M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $171.49M |
| Liabilities And Equity | $202.51M |
| Net Cash Flow From Operating Activities | -$34.41M |
| Net Cash Flow From Operating Activities, Continuing | -$34.41M |
| Net Cash Flow From Investing Activities | $25.94M |
| Net Cash Flow From Investing Activities, Continuing | $25.94M |
| Net Cash Flow From Financing Activities | $656.00K |
| Net Cash Flow From Financing Activities, Continuing | $656.00K |
| Net Cash Flow | -$7.82M |
| Net Cash Flow, Continuing | -$7.82M |
| Comprehensive Income/Loss | -$44.63M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$44.63M |
| Other Comprehensive Income/Loss | $0.00 |